Torrent Pharmaceuticals eyes more acquisitions in the future: Report

09 Jan 2014 Evaluate

After Rs 2,004-crore Torrent-Elder deal, Torrent Pharmaceuticals is reportedly eyeing more acquisitions in the future, both in domestic and overseas market. The company will prefer a much smaller acquisition, in the range of Rs 50-100 crore. Though, the company has not specified which areas it is going to foray for an acquisitions.

Earlier in December 2013, the company entered into a definitive binding agreement with Elder Pharmaceuticals (Elder) to acquire its branded domestic formulations business in India and Nepal (India Business) for a consideration of about Rs 2000 crore.

Torrent Pharmaceuticals is flagship company of the Torrent group, a leader in cardiovascular and central nervous system segments. It also has presence in gastro-intestinal, diabetology, anti-infective and pain management segments.

Torrent Pharma Share Price

3751.25 -41.40 (-1.09%)
30-Dec-2025 11:30 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1712.00
Dr. Reddys Lab 1267.30
Cipla 1488.30
Zydus Lifesciences 900.80
Lupin 2078.75
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×